At what cost? Debate rages over cholesterol drugs
August 06, 2015 at 12:13 PM EDT
Estimates of annual spending on PCSK9 drugs have been as high as $150 billion, but drugmakers expect it to be much lower.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|